Pages that link to "Q26751224"

The following pages link to The landscape of targeted therapies for cholangiocarcinoma: current status and emerging targets (Q26751224):

Displaying 34 items.

• Combined dabrafenib and trametinib treatment in a case of chemotherapy-refractory extrahepatic BRAF V600E mutant cholangiocarcinoma: dramatic clinical and radiological response with a confusing synchronic new liver lesion (Q33593231) (← links)
• Therapeutic options for intrahepatic cholangiocarcinoma (Q33621529) (← links)
• The potential role of comprehensive genomic profiling to guide targeted therapy for patients with biliary cancer (Q33656860) (← links)
• Synergistic antitumor activity of the combination of salubrinal and rapamycin against human cholangiocarcinoma cells (Q37709171) (← links)
• Integrated mRNA and lncRNA expression profiling for exploring metastatic biomarkers of human intrahepatic cholangiocarcinoma (Q37743528) (← links)
• The emerging role of mast cells in liver disease (Q39284642) (← links)
• Current biologics for treatment of biliary tract cancers (Q39453572) (← links)
• Advances in cholangiocarcinoma research: report from the third Cholangiocarcinoma Foundation Annual Conference (Q39673531) (← links)
• Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness. (Q42371988) (← links)
• Role of AP-2α and MAPK7 in the regulation of autocrine TGF-β/miR-200b signals to maintain epithelial-mesenchymal transition in cholangiocarcinoma (Q45412331) (← links)
• A phase 1 study combining the HER3 antibody seribantumab (MM-121) and cetuximab with and without irinotecan. (Q45959066) (← links)
• The deleterious interplay between tumor epithelia and stroma in cholangiocarcinoma. (Q46328640) (← links)
• Upregulation of B7-H4 promotes tumor progression of intrahepatic cholangiocarcinoma (Q47299042) (← links)
• JQ1 Induces DNA Damage and Apoptosis, and Inhibits Tumor Growth in a Patient-Derived Xenograft Model of Cholangiocarcinoma (Q47398665) (← links)
• Molecular mechanisms driving cholangiocarcinoma invasiveness: an overview. (Q47603972) (← links)
• Genotyping and mRNA profiling reveal actionable molecular targets in biliary tract cancers (Q50127508) (← links)
• Serum p53 antibody as a potential tumor marker in extrahepatic cholangiocarcinoma (Q50999536) (← links)
• Hypoxia-mediated miR-212-3p downregulation enhances progression of intrahepatic cholangiocarcinoma through upregulation of Rab1a. (Q52578129) (← links)
• New molecular and immunotherapeutic approaches in biliary cancer. (Q54476966) (← links)
• Transcriptomic analysis and mutational status of IDH1 in paired primary-recurrent intrahepatic cholangiocarcinoma. (Q55260649) (← links)
• A Case of Metastatic Biliary Tract Cancer Diagnosed Through Identification of an Mutation (Q57799080) (← links)
• EVI1 expression is associated with aggressive behavior in intrahepatic cholangiocarcinoma (Q57800253) (← links)
• [Overpression of miR-29b suppresses the proliferation and induces apoptosis of cholangiocarcinoma cells] (Q58126170) (← links)
• FOXM1 modulates 5-fluorouracil sensitivity in cholangiocarcinoma through thymidylate synthase (TYMS): implications of FOXM1-TYMS axis uncoupling in 5-FU resistance (Q59789223) (← links)
• Molecular Pathogenesis of Cholangiocarcinoma (Q64085995) (← links)
• Long term recurrence free survival in a stage IV gallbladder cancer treated with chemotherapy plus trastuzumab and salvage liver resection (Q91872582) (← links)
• Dependency of Cholangiocarcinoma on Cyclin D-Dependent Kinase Activity (Q91938819) (← links)
• Frequency and prognostic significance of isocitrate dehydrogenase 1 mutations in cholangiocarcinoma: a systematic literature review (Q92486905) (← links)
• Personalised approach in combined treatment of cholangiocarcinoma: a case report of healing from cholangiocellular carcinoma at stage IV (Q92486923) (← links)
• GATA1 gene silencing inhibits invasion, proliferation and migration of cholangiocarcinoma stem cells via disrupting the PI3K/AKT pathway (Q92920611) (← links)
• Targeted deep sequencing contributes to guiding personalized targeted therapy for advanced biliary tract cancer patients with non‑radical resection: A real‑world study (Q93173379) (← links)
• Loss of c-Jun N-terminal Kinase 1 and 2 Function in Liver Epithelial Cells Triggers Biliary Hyperproliferation Resembling Cholangiocarcinoma (Q96111263) (← links)
• A review of systemic therapy in biliary tract carcinoma (Q99580546) (← links)
• Wikidata:Database reports/Constraint violations/P275 (← links | edit)